Dr. Vaibhav Deokar is Principal Scientist at Formulation Development Team of R&D, Lupin Limited (Biotech Division), India. He has pursued M.Tech (Bioprocess Technology) from the Institute of Chemical Technology (ICT) (formerly UDCT), Mumbai and completed his doctoral research under Lupin’s ASCENT PhD program. He has authored research articles in peer reviewed journals and is a key contributor to 8 formulation patents for biopharmaceuticals. He has 16+ years of experience in developing formulations for complex biopharmaceuticals like peptides, fusion proteins, pegylated proteins and high concentration antibody formulations. He is responsible for fill-finish process development, characterization and technology transfer to internal and global drug product manufacturing facilities for Lupin. He has faced regulatory agencies like US FDA, EMEA, PMDA, ANVISA, HPRA for formulation and fill-finish process development related activities. He has special interests in new product development, product differentiation and enhancement strategies and has provided new differentiation strategies for products in pipeline.